American College of Rheumatology 2021 Convergence Highlights
Catch up on Rheumatology Network's top highlights of the ACR 2021 Convergence.
Karen H. Costenbader, MD, MPH: Clinical Rheumatology Year in Review
Karen H. Costenbader, MD, MPH, discusses her upcoming ACR Convergence presentation entitled, “Year in Review: Clinical Rheumatology."
Click the image to view the story.
Louis Bessette, MD, MSc: Pain Improvement and Patient-Reported Outcomes in Patients with Psoriatic Arthritis
Louis Bessette, MD, MSc, explains the impact of early pain improvement on patient-reported outcomes in patients with psoriatic arthritis.
Click the image to view the story.
Jeffrey Curtis, MD, MS, MPH: Malignancies in Patients with Rheumatoid Arthritis and Cardiovascular Risk
Jeffrey Curtis, MD, MS, MPH, discusses malignancies in older patients with rheumatoid arthritis and cardiovascular risks being treated with either tofacitinib or tumor necrosis factor (TNF) inhibitors.
Click the image to view the story.
Roy Fleischmann, MD: Efficacy of Olokizumab for Rheumatoid Arthritis Treatment
Roy Fleischmann, MD, explores the successful results of the novel IL-6 inhibitor, olokizumab, from 2 randomized clinical trials of the phase 3 global research program CREDO.
Click the image to view the story.
Kazuki Yoshida, ScD: Gout Treatment Strategies Regarding Cardiovascular Outcomes
Kazuki Yoshida, MD, MPH, ScD, discusses his ACR presentation entitled, “Comparative Safety of Gout "Treat-to-target" and "Usual Care" Treatment Strategies on Cardiovascular Outcomes Using Observational Data: Causal Inference Approach.”
Click the image to view the story.
